1j7y: Difference between revisions

New page: left|200px<br /> <applet load="1j7y" size="450" color="white" frame="true" align="right" spinBox="true" caption="1j7y, resolution 1.7Å" /> '''Crystal structure of...
 
No edit summary
Line 6: Line 6:
==Overview==
==Overview==
The effect of mutagenesis on O(2), CO, and NO binding to mutants of human, hemoglobin, designed to modify some features of the reactivity that hinder, use of hemoglobin solutions as blood substitute, has been extensively, investigated. The kinetics may be interpreted in the framework of the, Monod-Wyman-Changeux two-state allosteric model, based on the, high-resolution crystallographic structures of the mutants and taking into, account the control of heme reactivity by the distal side mutations. The, mutations involve residues at topological position B10 and E7, i.e., Leu, (B10) to Tyr and His (E7) to Gln, on either the alpha chains alone, (yielding the hybrid tetramer Hbalpha(YQ)), the beta chains alone (hybrid, tetramer Hbbeta(YQ)), or both types of chains (Hb(YQ)). Our data indicate, that the two mutations affect ligand diffusion into the pocket, leading to, proteins with low affinity for O(2) and CO, and especially with reduced, reactivity toward NO, a difficult goal to achieve. The observed kinetic, heterogeneity between the alpha(YQ) and beta(YQ) chains in Hb(YQ) has been, rationalized on the basis of the three-dimensional structure of the active, site. Furthermore, we report for the first time an experiment of partial, CO binding, selective for the beta chains, to high salt crystals of the, mutant Hb(YQ) in the T-state; these crystallographic data may be, interpreted as "snapshots" of the initial events possibly occurring on, ligand binding to the T-allosteric state of this peculiar mutant Hb.
The effect of mutagenesis on O(2), CO, and NO binding to mutants of human, hemoglobin, designed to modify some features of the reactivity that hinder, use of hemoglobin solutions as blood substitute, has been extensively, investigated. The kinetics may be interpreted in the framework of the, Monod-Wyman-Changeux two-state allosteric model, based on the, high-resolution crystallographic structures of the mutants and taking into, account the control of heme reactivity by the distal side mutations. The, mutations involve residues at topological position B10 and E7, i.e., Leu, (B10) to Tyr and His (E7) to Gln, on either the alpha chains alone, (yielding the hybrid tetramer Hbalpha(YQ)), the beta chains alone (hybrid, tetramer Hbbeta(YQ)), or both types of chains (Hb(YQ)). Our data indicate, that the two mutations affect ligand diffusion into the pocket, leading to, proteins with low affinity for O(2) and CO, and especially with reduced, reactivity toward NO, a difficult goal to achieve. The observed kinetic, heterogeneity between the alpha(YQ) and beta(YQ) chains in Hb(YQ) has been, rationalized on the basis of the three-dimensional structure of the active, site. Furthermore, we report for the first time an experiment of partial, CO binding, selective for the beta chains, to high salt crystals of the, mutant Hb(YQ) in the T-state; these crystallographic data may be, interpreted as "snapshots" of the initial events possibly occurring on, ligand binding to the T-allosteric state of this peculiar mutant Hb.
==Disease==
Known diseases associated with this structure: Erythremias, alpha- OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=141800 141800]], Erythremias, beta- OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=141900 141900]], Erythrocytosis OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=141850 141850]], HPFH, deletion type OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=141900 141900]], Heinz body anemia OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=141850 141850]], Heinz body anemias, alpha- OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=141800 141800]], Heinz body anemias, beta- OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=141900 141900]], Hemoglobin H disease OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=141850 141850]], Hypochromic microcytic anemia OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=141850 141850]], Methemoglobinemias, alpha- OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=141800 141800]], Methemoglobinemias, beta- OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=141900 141900]], Sickle cell anemia OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=141900 141900]], Thalassemia, alpha- OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=141850 141850]], Thalassemia-beta, dominant inclusion-body OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=141900 141900]], Thalassemias, alpha- OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=141800 141800]], Thalassemias, beta- OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=141900 141900]]


==About this Structure==
==About this Structure==
Line 26: Line 29:
[[Category: globin]]
[[Category: globin]]


''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Thu Nov 8 13:10:09 2007''
''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Mon Nov 12 17:38:03 2007''

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA